Amprius Technologies, Inc. current report, 16 January 2024

Amprius Technologies, Inc. — Form 8-K Summary

Reporting date: January 16, 2024. The filing reports product portfolio and supply-chain developments under Item 8.01; it does not provide quarterly or annual financial results.

Business Context

Amprius announced a new silicon-anode battery platform, SiCore, and rebranded its existing silicon nanowire platform as SiMaxx. SiCore batteries use proprietary silicon-anode materials developed by Berzelius (Nanjing) Co. Ltd. and are currently manufactured through toll manufacturing partners. Amprius expects both platforms to be produced at its planned large-scale factory in Colorado.

Financial and Operating Metrics

  • No revenue, profit, cash flow, margin, debt, liquidity, capitalization, or other financial metrics are reported in this filing.
  • The Exclusive Supply Agreement contains no commercial terms. Purchases, if any, will be governed by mutually agreed written purchase orders.
  • Berzelius agreed to manufacture and sell its proprietary silicon-anode materials exclusively to Amprius in the United States, Canada, and Mexico, and to use best efforts to prioritize Amprius’s forecasted orders.

Material Changes and Outlook

  • The principal change is the expansion of Amprius’s product portfolio through the SiCore platform and the formal branding of the existing SiMaxx platform.
  • Amprius expects to transition or expand production to its Colorado facility, but the filing does not provide a construction, permitting, production, capacity, or commercialization timetable.
  • The Exclusivity Agreement, dated November 28, 2023, remains effective until mutually terminated.

Risks, Contingencies, and Unusual Items

Management’s statements regarding future production and product expansion are forward-looking. Key risks include market demand for SiCore batteries; the ability to deliver high-performance products at acceptable prices; toll manufacturers’ ability to meet expected volumes, quality, and pricing; production-cost reductions; permitting, construction, and facility-operation delays; establishing Colorado manufacturing lines suitable for SiCore; achieving cost targets; customer demand; liquidity; competition; shortages of required materials; and domestic and international business, financial, political, and legal conditions.

The filing also identifies Berzelius as a related historical connection: before February 2022, it was a subsidiary of Amprius, Inc., a significant stockholder of Amprius Technologies. The filing does not disclose purchase prices, minimum purchase commitments, volume commitments, or other commercial terms.

Investor Verification Items

  • Verify the full Exclusive Supply Agreement and any omitted schedules, including exclusivity scope, termination provisions, and related-party implications.
  • Confirm whether and when SiCore manufacturing lines will be established and operational at the Colorado facility.
  • Assess toll-manufacturing capacity, product quality, pricing, and supply continuity for both SiCore and SiMaxx.
  • Review subsequent filings for liquidity, funding needs, customer orders, production milestones, and commercialization progress.
  • Note that the narrative references Exhibit 99.1, while the exhibit list identifies the Exclusive Supply Agreement as Exhibit 10.1; investors should verify the filed exhibit.